U.S. Markets closed

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.1100+0.0900 (+4.46%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 313.5800
52 Week Low 31.9300
50-Day Moving Average 32.4183
200-Day Moving Average 32.6825

Share Statistics

Avg Vol (3 month) 3214.08k
Avg Vol (10 day) 3227.47k
Shares Outstanding 546.1M
Float 15.83M
% Held by Insiders 129.86%
% Held by Institutions 158.09%
Shares Short (Aug 30, 2020) 41.66M
Short Ratio (Aug 30, 2020) 49.26
Short % of Float (Aug 30, 2020) 46.75%
Short % of Shares Outstanding (Aug 30, 2020) 43.59%
Shares Short (prior month Jul 30, 2020) 42.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.84%
Return on Equity (ttm)-182.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -102.01M
Net Income Avi to Common (ttm)-106.8M
Diluted EPS (ttm)-2.2750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.44M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)6.14M
Total Debt/Equity (mrq)15.09
Current Ratio (mrq)3.31
Book Value Per Share (mrq)0.88

Cash Flow Statement

Operating Cash Flow (ttm)-82.83M
Levered Free Cash Flow (ttm)-44.13M